Literature DB >> 23917094

Diagnosis and differential diagnosis of multiple sclerosis.

Ilana B Katz Sand1, Fred D Lublin.   

Abstract

PURPOSE OF REVIEW: When a patient presents with symptoms or imaging suggestive of multiple sclerosis (MS), making the correct diagnosis may at times be straightforward but in many cases is quite challenging. Symptoms may be difficult for patients to characterize and for clinicians to interpret; findings on examination may be subtle; imaging is not always specific; and the differential diagnosis of possible demyelinating disease is quite broad. Making a correct diagnosis of MS early in the disease course is likely to become even more important over time as new disease-modifying therapies, particularly those with potential neuroprotective benefits, are introduced. This article reviews the current diagnostic criteria for MS and illustrates their application as well as reviews the differential diagnosis for patients presenting with symptoms or imaging suggestive of demyelinating disease. RECENT
FINDINGS: The diagnostic criteria for MS were revised by the International Panel on Diagnosis of Multiple Sclerosis in 2010.
SUMMARY: The diagnostic criteria for MS have been revised several times over the years, most recently giving rise to the McDonald 2010 criteria. The diagnosis of MS begins with a patient who presents with symptoms typical for the disease, termed the "clinically isolated syndrome," which most commonly affects the optic nerves, brainstem, or spinal cord. If the patient's symptoms and imaging are typical for MS, the clinician can then apply the appropriate diagnostic criteria. If atypical clinical or imaging findings are present, alternative etiologies must be pursued as appropriate.

Entities:  

Mesh:

Year:  2013        PMID: 23917094     DOI: 10.1212/01.CON.0000433290.15468.21

Source DB:  PubMed          Journal:  Continuum (Minneap Minn)        ISSN: 1080-2371


  9 in total

1.  High-Resolution Expression Profiling of Peripheral Blood CD8+ Cells in Patients with Multiple Sclerosis Displays Fingolimod-Induced Immune Cell Redistribution.

Authors:  Luisa Roch; Michael Hecker; Jörg Friess; Ines Charlotte Angerer; Dirk Koczan; Brit Fitzner; Ina Schröder; Kristin Flechtner; Hans-Jürgen Thiesen; Stefanie Meister; Alexander Winkelmann; Uwe Klaus Zettl
Journal:  Mol Neurobiol       Date:  2016-09-08       Impact factor: 5.590

Review 2.  Myeloid disorders after autoimmune disease.

Authors:  Prajwal C Boddu; Amer M Zeidan
Journal:  Best Pract Res Clin Haematol       Date:  2019-02-07       Impact factor: 3.020

Review 3.  Differential diagnosis of Mendelian and mitochondrial disorders in patients with suspected multiple sclerosis.

Authors:  James D Weisfeld-Adams; Ilana B Katz Sand; Justin M Honce; Fred D Lublin
Journal:  Brain       Date:  2015-01-29       Impact factor: 13.501

Review 4.  PET imaging in multiple sclerosis.

Authors:  Daniele de Paula Faria; Sjef Copray; Carlos Buchpiguel; Rudi Dierckx; Erik de Vries
Journal:  J Neuroimmune Pharmacol       Date:  2014-05-09       Impact factor: 4.147

5.  Hormonal contraception and the development of autoimmunity: A review of the literature.

Authors:  William V Williams
Journal:  Linacre Q       Date:  2017-08-18

6.  High-Density Peptide Microarray Analysis of IgG Autoantibody Reactivities in Serum and Cerebrospinal Fluid of Multiple Sclerosis Patients.

Authors:  Michael Hecker; Brit Fitzner; Matthias Wendt; Peter Lorenz; Kristin Flechtner; Felix Steinbeck; Ina Schröder; Hans-Jürgen Thiesen; Uwe Klaus Zettl
Journal:  Mol Cell Proteomics       Date:  2016-02-01       Impact factor: 5.911

Review 7.  Paraoxonase 1 in neurological disorders.

Authors:  Teresita Menini; Alejandro Gugliucci
Journal:  Redox Rep       Date:  2013-11-12       Impact factor: 4.412

8.  Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS.

Authors:  Karen Ann Ribbons; Patrick McElduff; Cavit Boz; Maria Trojano; Guillermo Izquierdo; Pierre Duquette; Marc Girard; Francois Grand'Maison; Raymond Hupperts; Pierre Grammond; Celia Oreja-Guevara; Thor Petersen; Roberto Bergamaschi; Giorgio Giuliani; Michael Barnett; Vincent van Pesch; Maria-Pia Amato; Gerardo Iuliano; Marcela Fiol; Mark Slee; Freek Verheul; Edgardo Cristiano; Ricardo Fernandez-Bolanos; Maria-Laura Saladino; Maria Edite Rio; Jose Cabrera-Gomez; Helmut Butzkueven; Erik van Munster; Leontien Den Braber-Moerland; Daniele La Spitaleri; Alessandra Lugaresi; Vahid Shaygannejad; Orla Gray; Norma Deri; Raed Alroughani; Jeannette Lechner-Scott
Journal:  PLoS One       Date:  2015-06-05       Impact factor: 3.240

9.  Brain and spinal cord MRI lesions in primary progressive vs. relapsing-remitting multiple sclerosis.

Authors:  Akram Dastagir; Brian C Healy; Alicia S Chua; Tanuja Chitnis; Howard L Weiner; Rohit Bakshi; Shahamat Tauhid
Journal:  eNeurologicalSci       Date:  2018-07-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.